🟢 20/20 Biolabs is trading 6.7% up in after-hours trading — no confirmed catalyst identified

20/20 Biolabs is trading 6.7% higher at $0.40 in after-hours trading, with no verified company-specific catalyst identified for the October 9 move.

• The latest identified company news was an October 2 announcement that executives planned to participate in the October 13–14 Maxim Growth Summit; the event was announced in advance and does not establish a cause.
• Available evidence points to an unexplained move, not a confirmed earnings or news reaction.